Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Achillion Pharmaceuticals
4235
Achillion Pharmaceuticals
Health Care
Technology
Biotechnology
An innovative pharmaceutical company dedicated to meeting the needs of patients with HCV & ultra-rare diseases. Disclaimer on our site
Suggest edits
Founded
1998
Raised
$50.1M
Follow us
Companies in the same industry
Prometic
Rubitection Inc.
ENT Biotech Solutions, LLC
Intezyne Technologies
NanoCellect Biomedical
Palisade Therapeutics
Pionyr Immunotherapeutics
Arcturus Therapeutics
Cytena
Partner Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$50,100,000
Venture capital - 2010
Pappas Ventures
Clarus Ventures
Domain Associates
+1
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
The Motley Fool
Why Achillion Pharmaceuticals Is Down Big in 2016
The Motley Fool
Why Achillion Pharmaceuticals Jumped 10% in May
The Motley Fool
Why Achillion Pharmaceuticals Shares Crashed 37% in January
Stock markets
Health
The Motley Fool
Why Achillion Pharmaceuticals Shot 30% Higher in November --
Health
Earnings
Stock markets
The Motley Fool
Why Achillion Pharmaceuticals Shares Soared in October --
Stock markets
Health
The Motley Fool
Why Achillion Pharmaceuticals Shares Are Roaring Higher Today --
Stock markets
Health
